- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Exercise and epigenetic ages in older adults with myeloid malignancies ; volume:28 ; number:1 ; day:30 ; month:5 ; year:2023 ; pages:1-12 ; date:12.2023
European journal of medical research ; 28, Heft 1 (30.5.2023), 1-12, 12.2023
- Urheber
-
Loh, Kah Poh
Sanapala, Chandrika
Jensen-Battaglia, Marielle
Rana, Anish
Sohn, Michael B.
Watson, Erin
Gilmore, Nikesha
Klepin, Heidi D.
Mendler, Jason H.
Liesveld, Jane
Huselton, Eric
LoCastro, Marissa
Susiarjo, Martha
Netherby-Winslow, Colleen
Williams, AnnaLynn M.
Mustian, Karen
Vertino, Paula
Janelsins, Michelle C.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40001-023-01145-z
- URN
-
urn:nbn:de:101:1-2023091208221842448333
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loh, Kah Poh
- Sanapala, Chandrika
- Jensen-Battaglia, Marielle
- Rana, Anish
- Sohn, Michael B.
- Watson, Erin
- Gilmore, Nikesha
- Klepin, Heidi D.
- Mendler, Jason H.
- Liesveld, Jane
- Huselton, Eric
- LoCastro, Marissa
- Susiarjo, Martha
- Netherby-Winslow, Colleen
- Williams, AnnaLynn M.
- Mustian, Karen
- Vertino, Paula
- Janelsins, Michelle C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies
Chromothripsis in myeloid malignancies
Epigenetic gene silencing in concert with deletion of chromosome 7q in myeloid malignancies
The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
Myeloid malignancies: mutations, models and management
ASXL1/2 mutations and myeloid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Role of the microenvironment in myeloid malignancies
Mutations of c-Cbl in myeloid malignancies
Targeting self-renewal pathways in myeloid malignancies
AXL in myeloid malignancies – an elusive target?
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies
Chromothripsis in myeloid malignancies
Epigenetic gene silencing in concert with deletion of chromosome 7q in myeloid malignancies
The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
Myeloid malignancies: mutations, models and management
ASXL1/2 mutations and myeloid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Role of the microenvironment in myeloid malignancies
Mutations of c-Cbl in myeloid malignancies
Targeting self-renewal pathways in myeloid malignancies
AXL in myeloid malignancies – an elusive target?
Epigenetic inactivation of the MIR129-2 in hematological malignancies
Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies
Chromothripsis in myeloid malignancies
Epigenetic gene silencing in concert with deletion of chromosome 7q in myeloid malignancies
The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies
Myeloid malignancies: mutations, models and management
ASXL1/2 mutations and myeloid malignancies
Cohesin mutations in myeloid malignancies: underlying mechanisms
Role of the microenvironment in myeloid malignancies
Mutations of c-Cbl in myeloid malignancies
Targeting self-renewal pathways in myeloid malignancies
AXL in myeloid malignancies – an elusive target?